or Try an Advanced Search...

    ETF Components for FGM - First Trust Germany AlphaDex Fund


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    MRK A 2.93 2.86

    Represented by ETF Holdings

    Keywords: Amines Animal Health Animal Health Products Antibiotics Cac 40 Constipation Diabetes Dow Jones Component Drug Wholesalers ETN Fertility Food Chain Foot Care Products Health Maintenance Organizations Health Products Health Solutions Infectious Diseases Life Sciences Lotion Medication
    Industries: Drug Manufacturers - Major

    Recent News for First Trust Germany AlphaDex Fund & its Holdings

    Date Stock Title
    Apr 25 MRK Merck (MRK) Q1 2024 Earnings Call Transcript
    Apr 25 MRK Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
    Apr 25 MRK Merck & Co., Inc. (MRK) Q1 2024 Earnings Call Transcript
    Apr 25 MRK Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
    Apr 25 MRK Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
    Apr 25 MRK 20 Fastest Growing Health Tech Companies in the World
    Apr 25 MRK Merck raises 2024 guidance on cancer drug demand
    Apr 25 MRK Meta Falls 15% On Great Earnings, Tesla Rises 12% On Ugly Earnings – Here Is The Real Reason
    Apr 25 MRK Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
    Apr 25 MRK Merck raises guidance as Keytruda sales jump 20% in Q1
    Apr 25 MRK UPDATE 3-Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
    Apr 25 MRK Merck in charts: Pharmaceutical segment soars on KEYTRUDA, GARDASIL strength in Q1
    Apr 25 MRK Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
    Apr 25 MRK Merck Non-GAAP EPS of $2.07 beats by $0.15, revenue of $15.8B beats by $600M
    Apr 25 MRK Merck Announces First-Quarter 2024 Financial Results
    Apr 25 MRK Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
    Apr 25 MRK US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
    Apr 24 MRK Alphabet, Microsoft, Southwest earnings: What to watch
    Apr 24 MRK 4 Large Drug Stocks to Hold on to Amid Industry Challenges
    Apr 24 MRK Merck Q1 Earnings Preview: Strong quarter expectations on the back of core products' growth
    The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Defined Germany Index. The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in stocks and/or depositary receipts that comprise the index. It, using an "indexing" investment approach, attempts to replicate, before fees and expenses, the performance of the index. The index is designed by S&P to objectively identify and select securities from the S&P Germany BMI Index. The fund is non-diversified.
    Exchange Traded Fund ETF Index Fund Stock Market Index Germany Index S&P Gcc Investable Large Mid Cap Index Lcl
    Back to the Main FGM Page...